Literature DB >> 27084028

Posterior reversible encephalopathy syndrome and association with systemic lupus erythematosus.

T S Ferreira1, F Reis2, S Appenzeller3.   

Abstract

INTRODUCTION: Posterior reversible encephalopathy syndrome (PRES) is a neurological complex disorder with many clinical associations and causative factors. It is important to recognize this condition because early diagnosis and treatment usually result in its complete resolution, radiological imaging becoming the key for the correct diagnosis.
METHODS: We retrospectively reviewed charts and magnetic resonance imaging findings in the University of Campinas from January 2005 to July 2015, selecting three cases of patients with systemic lupus erythematosus syndrome who developed PRES, for whom risk factors, characteristics, magnetic resonance imaging findings and neurological resolution were analyzed. We also conducted a review of the English-language literature.
RESULTS: The three cases had neurological symptoms like acute onset of headache, altered mental status, cortical blindness and seizures. Brain magnetic resonance imaging demonstrated posterior cortical and white matter alterations involving posterior brain territories, which were more conspicuous on T2-weighted and fluid-attenuated inversion recovery. Spectroscopy, diffusion-weighted imaging and susceptibility-weighted imaging were also important for neuroradiological evaluation. Immunosuppressive drugs were taken in all cases. Partial clinical and radiological recovery was observed in two cases, and complete resolution was observed in the third patient. LITERATURE REVIEW: We found 52 cases of PRES in systemic lupus erythematosus patients. Almost all patients were women 94%, ranging from 8 to 62 years old. Posterior brain territory involvements were found in 98% of patients. Hemorrhagic complications involved 26% of patients, becoming a risk factor for clinical sequels. The total percentage of patients with no complete resolution of radiological findings on follow-up images was 27.5%. DISCUSSION: In patients with autoimmune disorders, endothelial dysfunction may occur secondary to autoimmunity and the use of cytotoxic drugs, supposedly facilitating the occurrence of more severe PRES. The hypothesis that patients with autoimmune diseases have a propensity to develop non-reversible lesions has been raised.
© The Author(s) 2016.

Entities:  

Keywords:  Posterior reversible encephalopathy syndrome; hypertension encephalopathy; systemic lupus erythematosus

Mesh:

Substances:

Year:  2016        PMID: 27084028     DOI: 10.1177/0961203316643598

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  3 in total

1.  Differential serum cytokine profile in patients with systemic lupus erythematosus and posterior reversible encephalopathy syndrome.

Authors:  J Merayo-Chalico; A Barrera-Vargas; G Juárez-Vega; J Alcocer-Varela; A Arauz; D Gómez-Martín
Journal:  Clin Exp Immunol       Date:  2018-01-16       Impact factor: 4.330

2.  Neurological manifestations in thrombotic microangiopathy: Imaging features, risk factors and clinical course.

Authors:  José Thiago de Souza de Castro; Simone Appenzeller; Marina Pereira Colella; Gabriela Yamaguti-Hayakawa; Erich Vinícius De Paula; Joyce Annichinno-Bizzachi; Fernando Cendes; Reis Fabiano; Fernanda Andrade Orsi
Journal:  PLoS One       Date:  2022-09-21       Impact factor: 3.752

3.  Clinical features, outcome, and associated factors for posterior reversible encephalopathy in Thai patients with systemic lupus erythematosus: a case-control study.

Authors:  Usanee Damrongpipatkul; Kanokporn Oranratanachai; Nuntana Kasitanon; Salita Wuttiplakorn; Worawit Louthrenoo
Journal:  Clin Rheumatol       Date:  2017-11-04       Impact factor: 3.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.